Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2008; 14(20): 3224-3230
Published online May 28, 2008. doi: 10.3748/wjg.14.3224
Figure 1
Figure 1 A: Bilirubin level ≥ 10 mg/dL at presentation was associated with decreased survival as compared to lower levels; B: Chemotherapy administration prolonged survival in cholangiocarcinoma patients; C: Surgery added survival benefit in patients with cholangiocarcinoma.